De novo use of everolimus reduces late-onset cytomegalovirus primary disease occurring after antiviral prophylaxis discontinuation in kidney transplantat recipients
(2017) Belgian Transplant Society — Location: Brussels (16.March.2017)
Files
No attached file found for this publication.
Details
- Authors
- Affiliations
Citations
Devresse, A. (2017). De novo use of everolimus reduces late-onset cytomegalovirus primary disease occurring after antiviral prophylaxis discontinuation in kidney transplantat recipients. Belgian Transplant Society, Brussels. https://hdl.handle.net/2078.5/266436